Blar i NTNU Open på forfatter "Vanky, Eszter Ilona"
-
Anthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero
Nilsen, Guro Ørndal; Simpson, Melanie Rae; Hanem, Liv Guro Engen; Løvvik, Tone Shetelig; Ødegård, Rønnaug Astri; Stokkeland, Live Marie T; Andersen, Marianne; Juliusson, Pétur Benedikt; Vanky, Eszter Ilona (Peer reviewed; Journal article, 2023)Introduction Fetal growth may be affected by both maternal polycystic ovary syndrome (PCOS) and metformin therapy. Here, we explore the effect of intrauterine metformin exposure on birth anthropometrics of infants born ... -
Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials
Ujvari, Dorina; Trouva, Anastasia; Hirschberg, Angelica Lindén; Vanky, Eszter Ilona (Peer reviewed; Journal article, 2023)Objective Serum prokineticin-1 (s-PROK1) in the second and third trimester of pregnancy is positively correlated to preeclampsia, intrauterine growth restriction (IUGR) and preterm delivery. Women with polycystic ovary ... -
SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
Garcia-Beltran, Cristina; Malpique, Rita; Andersen, Marianne S; Bas, Firdevs; Bassols, Judit; Darendeliler, Feyza; Díaz, Marta; Dieris, Barbara; Fanelli, Flaminia; Fröhlich-Reiterer, Elke; Gambineri, Alessandra; Glintborg, Dorte; López-Bermejo, Abel; Mann, Christopher; Marin, Silvia; Obermayer-Pietsch, Barbara; Ødegård, Rønnaug Astri; Ravn, Pernille; Reinehr, Thomas; Renzulli, Matteo; Salvador, Cristina; Singer, Viola; Vanky, Eszter Ilona; Torres, Juan Vicente; Yildiz, Melek; de Zegher, Francis; Ibáñez, Lourdes (Peer reviewed; Journal article, 2023)Background: Polycystic ovary syndrome (PCOS) is the most prevalent, chronic endocrine‑metabolic disorder of adolescents and young women (AYAs), affecting 5–10% of AYAs worldwide. There is no approved pharmacological therapy ...